BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals develops medicines for rare diseases, particularly hereditary angioedema (a condition that causes unpredictable swelling). The company sells ORLADEYO, a pill taken by mouth to treat hereditary angioedema, and RAPIVAB, an injectable antiviral for the flu. BioCryst is also testing several experimental drugs in clinical trials for hereditary angioedema, diabetic eye disease, skin conditions, and other rare illnesses.